Oracle Stock: The Market Is Missing Something BIG!
1 extracted signal · 0 resolved · 1 still active
The Patient InvestorIndependent analyst profile- Source published
- 03 Nov 2026, 18:48 UTC
- Recorded by Tahlil Plus
- 03 Nov 2026, 22:00 UTC

AI-generated source summary
Oracle's financial projections suggest a strong turnaround potential, despite recent stock price declines and a BBB-/A-3 S&P rating. The company forecasts significant growth in total revenues, aiming for over $225 billion by FY30. Key metrics include a projected non-GAAP EPS of $21.00+ and a 40%+ non-GAAP operating margin by FY30. Oracle expects to be fully funded and self-funded by FY28, with free cash flow projected at $30 billion plus by FY29, avoiding further debt issuance. The company's business model, focused on large contract RPO conversion to revenue, shows a positive trend with increasing quarterly revenues and a healthy 5-year average contract duration. Despite a high interest expense, the maturity of debt is well-spread, and low interest rates on borrowings mitigate immediate risk. The primary credit risk identified is Oracle's reliance on OpenAI, which accounts for roughly half of its RPO. However, the company's ability to generate significant future free cash flow and its potential for high ROI (28%) position it attractively for investors with a high risk tolerance.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
The Patient Investor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
